The pilot who saved 155 lives on the Hudson now faces a foe he cannot outfly: early-stage Alzheimer’s.
Story Snapshot
- Chesley “Sully” Sullenberger says he was diagnosed with early-stage Alzheimer’s in August 2025.
- He describes mild symptoms like trouble recalling names and repeating stories.
- He is receiving a monthly infusion aimed at slowing progression.
- He urges early testing and hopes others feel safe to speak up.
What Sullenberger Disclosed And When
Sullenberger publicly announced he has early-stage Alzheimer’s and dated his diagnosis to August 2025. He shared the news on his website and expanded on it in interviews. He said he is at the beginning of a long journey and will not let the disease define his life. He emphasized that he still looks forward to the future with his family. His words carry weight because they come straight from him, not through unnamed sources.
He listed the early signs he noticed. Names do not come as quickly. He sometimes repeats a story he recently told. His sleep is not as good. These are common early clues families spot before they seek an evaluation. He said his doctor, Gil Rabinovici of the University of California, San Francisco Medical Center, helped him grasp how common this disease is. That context shows he is under specialist care at a leading memory center.
How He Plans To Fight
Sullenberger said he receives a monthly infusion to slow the disease. Media reports did not name the drug, but the treatment cadence matches current options that target disease biology. He framed the diagnosis as a challenge to manage, not a reason to retreat. He urged people to get tested early because more options exist when you act sooner. That is practical advice backed by what leading clinics tell patients and families today.
He chose to speak with his wife, Lorrie, and daughter, Kelly, alongside him. That matters. Family often notices changes first and then helps keep routines and treatment on track. Their presence signals a united plan for what comes next. It also gives hope to other families who feel alone. He said he wants people living in the shadows to feel safe stepping forward to seek care and support.
Why This Disclosure Resonates Beyond One Family
When a public figure names a hard truth, people pay attention for a reason. Research shows that these announcements spark a surge of interest in screening, prevention, and treatment. That energy can move people off the fence and into a doctor’s office. It also pushes honest talk at the dinner table, which is where real planning begins. The pattern has shown up across many cases in recent years.
Doctors who work in dementia care argue that early, clear disclosure helps the person plan and keeps choice and dignity front and center. That view lines up with a basic value many Americans hold dear: tell the truth, face the facts, and take responsibility for the next step. Sullenberger’s message fits that frame. He is not asking for pity. He is modeling how to prepare while life is still rich with purpose.
What To Watch For Next
Expect Sullenberger to keep his focus on family, treatment, and advocacy. He has already turned his cockpit calm into a message for others: act early, lean on your team, and do not hide. That posture can cut stigma, which keeps too many families silent. Media outlets may chase the most dramatic lines, but the steady facts are the most useful ones here: he named the diagnosis, started therapy, and set a plan with his doctor and family.
A brief note of caution belongs here. He has not shared medical records or named the drug, which is his right. The public does not need his charts to understand the lesson. If you notice slips in names, repeated stories, or changes in sleep or mood, talk to a clinician. Get a workup, consider current treatments, and make a plan with the people you trust. That is how you steer through rough air and land the plane together.
Sources:
washingtontimes.com, people.com, sfchronicle.com, foxnews.com, ca.rollingstone.com, tmz.com, receive.nilenso.com
